Skip to content

Reliability Study Using Electrodermal Activity to Measure Sensory Processing in Children With and Without Autism Spectrum Disorder

Reliability of Electrodermal Activity: Quantifying Sensory Processing in Children With Autism Spectrum Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02646696
Enrollment
32
Registered
2016-01-06
Start date
2013-01-31
Completion date
2014-05-31
Last updated
2016-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

The purpose of this study is tTho establish test-retest reliability of electrodermal markers used to quantify physiologic response to sensation using the Sensory Challenge Protocol in children with and without Autism Spectrum Disorder (ASD).

Detailed description

This methodological research design is a prospective exploratory test-retest design assessing the use of electrodermal activity (EDA) as an index of sensory processing. EDA will be measured using skin conductance response (SCR). The purpose of this study is to investigate if using EDA is a reliable measure over time within the context of response to sensation. Scores from test one and test two of each subject will be correlated to determine reliability of EDA measure. Reliability in this context will establish the utility of EDA as an index of sensory processing. Testing will occur two times within a six week period.

Interventions

Measurement of electrodermal activity in response to sensation

Sponsors

Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
4 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

Boys ages 4 - 11 years old. * Able to sit for 30 minutes and follow simple directions. * Children with confirmed Autism Spectrum Disorder via school records or parent report. * Typically developing children free of medical or neurological conditions

Exclusion criteria

* Medical or neurological conditions other than Autism. * Hearing loss or visual impairments. * Children taking medications known to affect arousal. * Children who are not able to follow simple commands.

Design outcomes

Primary

MeasureTime frame
Electrodermal Activity in response to sensationwithin six weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026